Article Versions Notes

Casablanca Y, Wang G, Lankes HA, Tian C, Bateman NW, Miller CR, Chappell NP, Havrilesky LJ, Wallace AH, Ramirez NC, et al. Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. Cancers. 2022; 14(17):4070. https://doi.org/10.3390/cancers14174070

Casablanca, Yovanni, Guisong Wang, Heather A. Lankes, Chunqiao Tian, Nicholas W. Bateman, Caela R. Miller, Nicole P. Chappell, Laura J. Havrilesky, Amy Hooks Wallace, Nilsa C. Ramirez, and et al. 2022. "Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study" Cancers 14, no. 17: 4070. https://doi.org/10.3390/cancers14174070

Casablanca, Y., Wang, G., Lankes, H. A., Tian, C., Bateman, N. W., Miller, C. R., Chappell, N. P., Havrilesky, L. J., Wallace, A. H., Ramirez, N. C., Miller, D. S., Oliver, J., Mitchell, D., Litzi, T., Blanton, B. E., Lowery, W. J., Risinger, J. I., Hamilton, C. A., Phippen, N. T., ... Maxwell, G. L. (2022). Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. Cancers, 14(17), 4070. https://doi.org/10.3390/cancers14174070